US Broker Ratings

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Anticipating a 62.99% Upside in the Rare Disease Sector

For investors with a keen eye on the healthcare sector, Eton Pharmaceuticals, Inc. (NASDAQ: ETON) presents a compelling opportunity. Specializing in the development and commercialization of treatments for rare diseases,..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a Potential 214% Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA) is capturing investor attention with its promising potential upside of 214%. Specializing in the development and commercialization of therapeutics for kidney disease patients, Akebia operates..

Avadel Pharmaceuticals (AVDL) Stock Analysis: Navigating a 54.90% Revenue Growth in the Healthcare Sector

Avadel Pharmaceuticals plc (NASDAQ: AVDL), a biopharmaceutical company headquartered in Dublin, Ireland, is making waves in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic..

STAAR Surgical Company (STAA): Investor Outlook with Key Insights into Growth Potential and Market Position

STAAR Surgical Company (NASDAQ: STAA), a prominent player in the medical instruments and supplies industry, offers a compelling case for investors seeking opportunities in the healthcare sector. Specializing in the..

Akso Health Group (AHG): Investor Outlook on a Fast-Growing Chinese E-Commerce Platform

As Akso Health Group (NASDAQ: AHG) continues to make waves in the healthcare sector, individual investors are taking a closer look at this emerging player in the medical distribution industry...

Auna SA (AUNA) Stock Analysis: 44.58% Potential Upside Amidst Healthcare Expansion

Auna SA (AUNA), a key player in the medical care facilities sector, is currently capturing investor interest with its notable potential upside of 44.58%. Based in Luxembourg and operating across..

Claritev Corporation (CTEV) Stock Analysis: Unpacking the 179% Potential Upside

For individual investors eyeing the healthcare sector, Claritev Corporation (NASDAQ: CTEV) presents an intriguing opportunity. With its focus on data analytics and technology-enabled solutions for cost management and revenue integrity..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: A Biotech Powerhouse with 138.61% Potential Upside

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) stands out in the biotechnology sector as a promising clinical-stage company, capturing investor attention with its compelling growth potential. Headquartered in Dallas, Texas, Taysha..

Nutex Health Inc. (NUTX) Investor Outlook: Strong Analyst Consensus and Potential Upside of 154.76%

For investors seeking opportunities in the healthcare sector, Nutex Health Inc. (NUTX) stands out with its compelling growth potential and strong analyst recommendations. Headquartered in Houston, Texas, Nutex Health operates..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A Promising 91.55% Upside Potential Awaits Investors

Castle Biosciences, Inc. (NASDAQ: CSTL), headquartered in Friendswood, Texas, operates within the healthcare sector, focusing on the diagnostics and research industry. The company is renowned for its cutting-edge molecular diagnostics..

Zymeworks Inc. (ZYME) Stock Analysis: Exploring a 70% Upside Potential with Strong Buy Ratings

Zymeworks Inc. (NASDAQ: ZYME) has garnered significant attention in the biotechnology sector, drawing investor interest with its innovative approach to developing biotherapeutics for cancer, inflammation, and autoimmune diseases. With a..

Dianthus Therapeutics (DNTH) Stock Analysis: A Biotech Gem with a 55% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a burgeoning name in the biotechnology landscape, is catching the eye of investors with its promising pipeline and significant growth potential. This clinical-stage company, headquartered..

REGENXBIO Inc. (RGNX) Stock Analysis: A Biotech Innovator with 206% Upside Potential

REGENXBIO Inc. (NASDAQ: RGNX), a prominent player in the biotechnology sector, is attracting considerable attention from investors, thanks to its innovative gene therapy portfolio and an impressive potential upside of..

Capricor Therapeutics (CAPR) Stock Analysis: Exploring a 56.59% Potential Upside in a Pioneering Biotech

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is making waves in the biotechnology sector with its innovative approach to tackling diseases with unmet medical needs. Headquartered in San Diego, California, this clinical-stage..

Butterfly Network, Inc. (BFLY) Stock Analysis: Unveiling a 52.82% Potential Upside in the Medical Device Sector

As investors continue to explore opportunities within the healthcare sector, Butterfly Network, Inc. (NYSE: BFLY) presents an intriguing case with its promising technological innovations and substantial growth potential. Specializing in..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: A Biotechnology Company with 139% Potential Upside

Investors seeking opportunities in the biotechnology sector might find Gyre Therapeutics, Inc. (NASDAQ: GYRE) an intriguing prospect. With its focus on developing small-molecule drugs targeting organ fibrosis, Gyre Therapeutics is..

iRadimed Corporation (IRMD) Stock Analysis: A 20.76% Upside in the Magnetic Healthcare Market

iRadimed Corporation (NASDAQ: IRMD) has carved out a niche in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.26 billion, iRadimed is a notable..

SI-BONE, Inc. (SIBN)

⚠️ No article content returned.

..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech Powerhouse with a Potential 98% Upside

Praxis Precision Medicines, Inc (NASDAQ: PRAX) is making waves in the healthcare sector, specifically within the biotechnology industry, with its robust pipeline of therapies targeting central nervous system (CNS) disorders...

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: High Revenue Growth Propels Interest Despite Challenging Valuation Metrics

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a burgeoning player in the biotechnology sector, has been capturing attention with its impressive revenue growth figures despite the complex dynamics of its financial..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds